Cargando…
Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: New insight for treating COVID-19
SARS-CoV-2 has caused up to 127 million cases of COVID-19. Approximately 5% of COVID-19 patients develop severe illness, and approximately 40% of those with severe illness eventually die, corresponding to more than 2.78 million people. The pathological characteristics of COVID-19 resemble typical se...
Autores principales: | Chen, Li, Huang, Qiong, Zhao, Tianjiao, Sui, Lihua, Wang, Shuya, Xiao, Zuoxiu, Nan, Yayun, Ai, Kelong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205260/ https://www.ncbi.nlm.nih.gov/pubmed/34174559 http://dx.doi.org/10.1016/j.redox.2021.102046 |
Ejemplares similares
-
Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries
por: Zhao, Tianjiao, et al.
Publicado: (2021) -
Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury
por: Liu, Min, et al.
Publicado: (2022) -
Nanotherapy and Reactive Oxygen Species (ROS) in Cancer: A Novel Perspective
por: Brenneisen, Peter, et al.
Publicado: (2018) -
Nanodrugs alleviate acute kidney injury: Manipulate RONS at kidney
por: Chen, Qiaohui, et al.
Publicado: (2022) -
ROS-Scavenging Nanomaterials to Treat Periodontitis
por: Sui, Lihua, et al.
Publicado: (2020)